Pregled bibliografske jedinice broj: 344231
BRCA1 and BRCA2 polymorphism screening in healthy women in Croatia
BRCA1 and BRCA2 polymorphism screening in healthy women in Croatia // Sažeci Četvrtog hrvatskog kongresa iz humane genetike s međunarodnim sudjelovanjem / Paediatria Croatica 51 (Suppl.) / Barišić, Ingeborg (ur.).
Zagreb: Klinika za dječje bolesti, 2007. str. 163-163 (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 344231 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
BRCA1 and BRCA2 polymorphism screening in healthy
women in Croatia
Autori
Levačić Cvok, Mirela ; Musani, Vesna ; Čretnik, Maja ; Ozretić, Petar ; Levanat, Sonja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Sažeci Četvrtog hrvatskog kongresa iz humane genetike s međunarodnim sudjelovanjem / Paediatria Croatica 51 (Suppl.)
/ Barišić, Ingeborg - Zagreb : Klinika za dječje bolesti, 2007, 163-163
Skup
Četvrti hrvatski kongres iz humane genetike
Mjesto i datum
Malinska, Hrvatska, 18.10.2007. - 20.10.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
BRCA1 ; BRCA2 ; polymorphism ; high-resolution melting
Sažetak
BRCA1 and BRCA2 are the major genes predisposing to breast and ovarian cancer. Mutations in either of these tumor suppressor genes are associated with both sporadic and hereditary forms of breast cancer. In hereditary cancer, a person inherits one mutated copy of either one of these genes. Tumorigenesis occurs when in addition to having a mutated copy individual develops an inactivating mutation of the remaining healthy allele. Breast cancer is the most common malignant disease of female population, and the second most common malignancy-related cause of death. At least ten percent of cases are attributable to familial inheritance. In Croatia, more than 2200 new cases of breast cancer are diagnosed each year, and about 800 women die of this malignancy. We analyzed the distribution and occurrence of polymorphisms in BRCA1 and BRCA2 genes on a healthy population of women in Croatia in an attempt to distinguish non-tumorigenic from tumorigenic changes in genomic sequences of BRCA1 and BRCA2 genes. This will contribute to easier distinction of potentially dangerous from harmless changes in patients with family history of breast cancer. From a wide range of conventional mutation screening methods based on conformational polymorphisms, we decided to use the procedures based on high resolution melting approach. In total, we analyzed 230 samples for BRCA1 gene and 140 samples for BRCA2 gene. We found 20 different polymorphisms of BRCA1 and 35 of BRCA2 gene.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-098-0982464-2461 - Prijenos signala u tumorima: Hh-Gli put, interakcije i potencijalne terapije (Levanat, Sonja, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus